Cardiopulmonary Stress Testing Systems Market Trends [2031]
Cardiopulmonary Stress Testing Systems Market Trends [2031]
Segments - Cardiopulmonary Stress Testing Systems Market by Product Type (Cardiopulmonary Exercise Testing, Pulse Oximeters, Single Photon Emission Computed Tomography, Stress Blood Pressure Monitors, Exercise Testing Systems, Stress ECG, and Others), End-user (Specialty Clinics, Hospitals, Ambulatory Surgical Centers, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-5898
| 4.7 Rating
| 52 Reviews
| 194 Pages
| Format :
Report Description
Cardiopulmonary Stress Testing Systems Market Outlook 2031
The global cardiopulmonary stress testing systems market size was valued at USD 5.66 billion in 2022 and is likely to reach USD 9.48 billion by 2031, expanding at a CAGR of 5.9% during 2023 – 2031. The growth of the market is attributed to the growing demand for remote and telehealth solutions.
Increasing number of people with heart and lung issues is resulting growing utilization of cardiopulmonary stress testing systems for managing these conditions which further boosts the market. Cardiopulmonary stress testing provides a comprehensive assessment of a patient's heart and lung function.
This information assists healthcare providers in tailoring treatment plans and monitoring patients over time. Moreover, the rising death rate caused by cardiovascular diseases is contributing to fueling the demand for these technologies.
-
According to the report published by the World Health Organization (WHO) on June 11, 2021, reveals that cardiovascular diseases are the major deaths causes globally. Around 17.9 million people lost their lives due to the CVDs in 2019, which accounts for 32% of all global deaths. Additionally, out of these deaths, 85% are caused by heart attacks and strokes.
Cardiopulmonary stress testing system or CPET system is a medical tool used to assess a person's cardiovascular and respiratory health during physical exertion. This system measures various parameters, such as heart rate, oxygen consumption, carbon dioxide production, and breathing patterns while a person exercises.
These measurements provide valuable information about the efficiency of the heart and lungs in delivering oxygen to the body. Additionally, this technology helps in diagnosing and monitoring cardiovascular and pulmonary conditions, including heart disease, asthma, or chronic obstructive pulmonary disease (COPD).
The COVID-19 pandemic moderately impacted the market. The increased focus on respiratory health and the potential long-term effects of the pandemic on the heart and lungs have raised awareness about the importance of cardiopulmonary assessment.
This created a growing demand for these testing systems in healthcare facilities. On the other hand, the pandemic also disrupted supply chains and led to delays in the production and distribution of medical equipment, including CPET systems.
Artificial Intelligence (AI) Impact on Cardiopulmonary Stress Testing Systems Market
Emergence of artificial intelligence is expected to propel the market. AI-driven advancements have streamlined data analysis and interpretation of assessing cardiovascular and respiratory health. Moreover, AI-powered algorithms are quickly and accurately analyze the data collected during stress tests, extracting valuable insights and flagging anomalies.
Cardiopulmonary Stress Testing Systems Market Dynamics
Major Drivers
Rising number of elder populations is expected to drive the market during the forecast period. Older individuals often suffer from various diseases, such as heart disease, hypertension, respiratory problems, and others.
Cardiopulmonary stress tests provide critical information to healthcare providers for tailoring treatment plans for the unique health requirements of these elderly patients. Additionally, these stress testing systems help identify these issues at an early stage for timely interventions which further propels market growth.
-
According to a report published by the World Health Organization (WHO) on October 1, 2022, the proportion of the global population over the age of 60 is estimated to nearly double from 12% in 2015 to 22% in 2050.
Existing Restraints
High cost of these advanced stress testing technology is expected to hinder the market. These systems often involve expensive equipment and specialized expertise which makes them less accessible for lower-resource healthcare settings.
This cost limits their availability to a broader population and smaller healthcare facilities. Additionally, stringent regulations and norms are anticipated to hinder the market during the projected period.
Emerging Opportunities
Growing adoption of telehealth and remote monitoring technology is expected to create immense opportunities for the market players competing in the market. Manufacturers are integrating these technologies into cardiopulmonary stress testing systems offering remote patients to perform tests.
This allows patients to perform tests at home while healthcare providers monitor their progress and results in real-time. Furthermore, the increasing demand for personalized medicines boosts the demand for cardiopulmonary stress testing systems for the planning of tailored treatment.
Scope of the Cardiopulmonary Stress Testing Systems Market Report
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Cardiopulmonary Stress Testing Systems Market- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Type (Cardiopulmonary Exercise Testing, Pulse Oximeters, Single Photon Emission Computed Tomography, Stress Blood Pressure Monitors, Exercise Testing Systems, Stress ECG, and Others) and End-user (Specialty Clinics, Hospitals, Ambulatory Surgical Centers, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Cardinal Health; Care Quality Commission; COSMED srl; General Electric; Halma plc; Hill-Rom Services Inc; Koninklijke Philips N.V; Masimo; MGC Diagnostics Corporation; NIHON KOHDEN CORPORATION; Schiller Americas, inc; Thermo Fisher Scientific Inc; VYAIRE; and ZOLL Medical Corporation |
Cardiopulmonary Stress Testing Systems Market Segment Insights
Type Analysis
Based on type, the cardiopulmonary stress testing systems market is divided into cardiopulmonary exercise testing, pulse oximeters, single photon emission computed tomography, stress blood pressure monitors, exercise testing systems, stress ECG, and others.
The exercise testing systems segment is expected to hold a major market revenue share during the forecast period due to their increasing demand from physicians and patients for its cost-effectiveness.
Cardiopulmonary exercise testing systems provide an overall view of a patient's health by evaluating the heart's performance and respiratory system response under stress. This comprehensive data is important for diagnosing various conditions, including heart disease to lung disorders.
Additionally, the high accuracy of the exercise testing system to detect subtle abnormalities further contributes to fueling the segment growth.
The stress ECG segment is anticipated to register robust growth during the forecast period, as they are particularly effective in identifying coronary artery disease (CAD) which is helpful for the detection of heart conditions.
It detects changes in the heart's electrical activity that occur when blood flow to the heart muscle is reduced due to blocked arteries. Moreover, the non-invasive nature of stress ECG is further boosting their demand.
End-user Analysis
In terms of end-user, the cardiopulmonary stress testing systems market is fragmented into specialty clinics, hospitals, ambulatory surgical centers, and others. The hospitals are projected to register a considerable CAGR during the forecast period due to the increasing demand for cardiopulmonary stress testing devices to cater to emergency cases related to heart and respiratory conditions.
Cardiopulmonary stress testing is often essential in these high-stakes situations to quickly and accurately assess a patient's condition. Moreover, the hospitals are equipped with the required infrastructure, specialized medical staff, and resources to perform cardiopulmonary stress tests which further fuels the market growth.
Regional Outlook
In terms of region, the global cardiopulmonary stress testing systems market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market due to its well-developed and advanced healthcare infrastructure with modern medical facilities and technologies.
This infrastructure supports the widespread adoption of cardiopulmonary stress testing systems. Furthermore, the high prevalence of cardiovascular diseases further boosts the demand for cardiopulmonary stress testing systems for early disease detection and management.
-
According to the report published by the Centers for Disease Control and Prevention on May 15, 2023, states that heart disease is the leading reason of death in the U.S. Approximately 695,000 people lost their lives to heart disease in 2021, which means that one in every five deaths in the U.S. is caused by heart disease.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years due to rapid urbanization leading to lifestyle changes that impact health. Physical inactivity and changing dietary habits are increasing the risk of heart and lung conditions and creating need for diagnostic tools, including cardiopulmonary stress testing. Additionally, the increasing elder population further facilitates the demand for cardiopulmonary stress testing for diagnostic services.
-
According to a report published by the United States Census Bureau on June 21, 2022, the population of Asia has exceeded 4.5 billion, which is more than half of the world's total population in 2020. The report also estimates that there were around 414 million people aged 65 and older in Asia, which is about 20% higher than the total population of the U.S. which is 331.4 million.
Segments
The global cardiopulmonary stress testing systems market has been segmented on the basis of
Type
- Cardiopulmonary Exercise Testing
- Pulse Oximeters
- Single Photon Emission Computed Tomography
- Stress Blood Pressure Monitors
- Exercise Testing Systems
- Stress ECG
- Others
End-user
- Specialty Clinics
- Hospitals
- Ambulatory Surgical Centers
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Cardinal Health
- Care Quality Commission
- COSMED srl
- General Electric
- Halma plc
- Hill-Rom Services Inc
- Koninklijke Philips N.V.
- Masimo
- MGC Diagnostics Corporation
- NIHON KOHDEN CORPORATION
- Schiller Americas, inc
- Thermo Fisher Scientific Inc
- VYAIRE
- ZOLL Medical Corporation
Competitive Landscape
Key players competing in the global cardiopulmonary stress testing systems market are Cardinal Health; Care Quality Commission; COSMED srl; General Electric; Halma plc; Hill-Rom Services Inc; Koninklijke Philips N.V; Masimo; MGC Diagnostics Corporation; NIHON KOHDEN CORPORATION; Schiller Americas, inc; Thermo Fisher Scientific Inc; VYAIRE; and ZOLL Medical Corporation
Manufacturing is focusing on various strategies such as partnerships, mergers, reduction in production costs, launching new products, and implementing advanced AI technologies to expand their market share.
-
On February 3, 2022, InBody, a leading provider of portable healthcare technology, announced the launch of the BP 170 Consumer Blood Pressure Device. This is InBody's latest at-home automatic blood pressure monitor that uses the oscillometric method to more accurately track daily changes in systolic and diastolic blood pressure, as well as pulse rate.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Cardiopulmonary Stress Testing Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cardiopulmonary Stress Testing Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cardiopulmonary Stress Testing Systems Market - Supply Chain
4.5. Global Cardiopulmonary Stress Testing Systems Market Forecast
4.5.1. Cardiopulmonary Stress Testing Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cardiopulmonary Stress Testing Systems Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cardiopulmonary Stress Testing Systems Market Absolute $ Opportunity
5. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Types
5.3.1. Cardiopulmonary Exercise Testing
5.3.2. Pulse Oximeters
5.3.3. Single Photon Emission Computed Tomography
5.3.4. Stress Blood Pressure Monitors
5.3.5. Exercise Testing Systems
5.3.6. Stress ECG
5.3.7. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by End Users
6.3.1. Specialty Clinics
6.3.2. Hospitals
6.3.3. Ambulatory Surgical Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Cardiopulmonary Stress Testing Systems Demand Share Forecast, 2019-2026
8. North America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Types
8.4.1. Cardiopulmonary Exercise Testing
8.4.2. Pulse Oximeters
8.4.3. Single Photon Emission Computed Tomography
8.4.4. Stress Blood Pressure Monitors
8.4.5. Exercise Testing Systems
8.4.6. Stress ECG
8.4.7. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by End Users
8.7.1. Specialty Clinics
8.7.2. Hospitals
8.7.3. Ambulatory Surgical Centers
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Cardiopulmonary Stress Testing Systems Demand Share Forecast, 2019-2026
9. Latin America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Types
9.4.1. Cardiopulmonary Exercise Testing
9.4.2. Pulse Oximeters
9.4.3. Single Photon Emission Computed Tomography
9.4.4. Stress Blood Pressure Monitors
9.4.5. Exercise Testing Systems
9.4.6. Stress ECG
9.4.7. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by End Users
9.7.1. Specialty Clinics
9.7.2. Hospitals
9.7.3. Ambulatory Surgical Centers
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Cardiopulmonary Stress Testing Systems Demand Share Forecast, 2019-2026
10. Europe Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Types
10.4.1. Cardiopulmonary Exercise Testing
10.4.2. Pulse Oximeters
10.4.3. Single Photon Emission Computed Tomography
10.4.4. Stress Blood Pressure Monitors
10.4.5. Exercise Testing Systems
10.4.6. Stress ECG
10.4.7. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by End Users
10.7.1. Specialty Clinics
10.7.2. Hospitals
10.7.3. Ambulatory Surgical Centers
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Cardiopulmonary Stress Testing Systems Demand Share Forecast, 2019-2026
11. Asia Pacific Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Types
11.4.1. Cardiopulmonary Exercise Testing
11.4.2. Pulse Oximeters
11.4.3. Single Photon Emission Computed Tomography
11.4.4. Stress Blood Pressure Monitors
11.4.5. Exercise Testing Systems
11.4.6. Stress ECG
11.4.7. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by End Users
11.7.1. Specialty Clinics
11.7.2. Hospitals
11.7.3. Ambulatory Surgical Centers
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Cardiopulmonary Stress Testing Systems Demand Share Forecast, 2019-2026
12. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by Types
12.4.1. Cardiopulmonary Exercise Testing
12.4.2. Pulse Oximeters
12.4.3. Single Photon Emission Computed Tomography
12.4.4. Stress Blood Pressure Monitors
12.4.5. Exercise Testing Systems
12.4.6. Stress ECG
12.4.7. Others
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size and Volume Forecast by End Users
12.7.1. Specialty Clinics
12.7.2. Hospitals
12.7.3. Ambulatory Surgical Centers
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Cardiopulmonary Stress Testing Systems Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Cardiopulmonary Stress Testing Systems Market: Market Share Analysis
13.2. Cardiopulmonary Stress Testing Systems Distributors and Customers
13.3. Cardiopulmonary Stress Testing Systems Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Cardinal Health
13.4.2. Care Quality Commission
13.4.3. COSMED srl
13.4.4. General Electric
13.4.5. Halma plc
13.4.6. Hill-Rom Services Inc
13.4.7. Koninklijke Philips N.V.
13.4.8. Masimo
13.4.9. MGC Diagnostics Corporation
13.4.10. NIHON KOHDEN CORPORATION
13.4.11. Schiller Americas, inc
13.4.12. Thermo Fisher Scientific Inc
13.4.13. VYAIRE
13.4.14. ZOLL Medical Corporation
Methodology
Related Reports
Some other reports from this category!
Our Clients
